Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer-Reference-Cited by-同舟云学术

Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer

Published:2013-04-23 Issue:5 Volume:34 Page:2605-2609
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Liang Shu-Hui,Yan Xi-Zhang,Wang Biao-Luo,Jin Hai-Feng,Yao Li-Ping,Li Ya-Ni,Chen Min,Nie Yong-Zhan,Wang Xin,Guo Xue-Gang,Wu Kai-Chun,Ding Jie,Fan Dai-Ming

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-013-0808-x.pdf

Reference15 articles.

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

2. Jackson C, Cunningham D, Oliveira J, ESMO Guidelines Working Group. Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20:34–6.

3. Overdier DG, Porcella A, Costa RH. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol. 1994;14:2755–66.

4. Hoggatt AM, Kriegel AM, Smith AF, Herring BP. Hepatocyte nuclear factor-3 homologue 1 (HFH-1) represses transcription of smooth muscle-specific genes. J Biol Chem. 2000;275:31162–70. doi: 10.1074/jbc.M005595200 .

5. Feuerborn A, Srivastava PK, Küffer S, Grandy WA, Sijmonsma TP, Gretz N, et al. The Forkhead factor FoxQ1 influences epithelial differentiation. J Cell Physiol. 2011;226:710–9. doi: 10.1002/jcp.22385 .

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The tumor suppressor p53 is a negative regulator of the carcinoma-associated transcription factor FOXQ1;Journal of Biological Chemistry;2024-04

2. The FGFR1 Signaling Pathway Upregulates the Oncogenic Transcription Factor FOXQ1 to Promote Breast Cancer Cell Growth;International Journal of Biological Sciences;2023

3. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway;World Journal of Gastroenterology;2022-05-07

4. DICER-AS1 functions as competing endogenous RNA that targets CSR1 by sponging microRNA-650 and suppresses gastric cancer progression;Journal of International Medical Research;2021-09

5. Tumor Forkhead Box Q1 Is Elevated, Correlates with Increased Tumor Size, International Federation of Gynecology and Obstetrics Stage but Worse Overall Survival in Epithelial Ovarian Cancer Patients;Cancer Biotherapy and Radiopharmaceuticals;2021-03-23